Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
40.13
+6.14 (18.06%)
At close: Mar 9, 2026, 4:00 PM EDT
42.48
+2.35 (5.86%)
After-hours: Mar 9, 2026, 7:51 PM EDT
Nanobiotix Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,881 | 148 | 346 | 135 | 289 | 581 | |
| Market Cap Growth | 965.30% | -57.08% | 156.46% | -53.41% | -50.20% | 179.88% | |
| Enterprise Value | 1,907 | 131 | 382 | 116 | 231 | 612 | |
| Last Close Price | 40.13 | 2.87 | 7.28 | 3.67 | 8.10 | 16.50 | |
| PS Ratio | 157.64 | -19.94 | 8.64 | 26.42 | 96.13 | 204.34 | |
| PB Ratio | - | -2.18 | -169.73 | -4.66 | 9.50 | 6.74 | |
| P/TBV Ratio | - | - | - | - | 9.50 | 6.74 | |
| EV/Sales Ratio | 159.82 | - | 9.53 | 22.66 | 76.63 | 215.20 | |
| Debt / Equity Ratio | -0.74 | -0.77 | -27.44 | -1.97 | 1.72 | 0.70 | |
| Net Debt / Equity Ratio | -0.32 | -0.02 | 13.41 | -0.44 | -1.41 | -1.00 | |
| Net Debt / EBITDA Ratio | -0.51 | -0.02 | 1.04 | -0.27 | 0.83 | 2.01 | |
| Net Debt / FCF Ratio | -0.71 | -0.06 | 1.93 | -0.32 | 1.26 | 2.54 | |
| Asset Turnover | 0.15 | - | 0.47 | 0.06 | 0.02 | 0.02 | |
| Quick Ratio | 0.58 | 0.98 | 1.68 | 1.23 | 2.38 | 6.42 | |
| Current Ratio | 0.63 | 1.04 | 1.75 | 1.38 | 2.53 | 6.58 | |
| Return on Equity (ROE) | - | - | - | - | -96.66% | -97.99% | |
| Return on Assets (ROA) | -41.64% | -52.89% | -19.72% | -35.38% | -25.00% | -24.06% | |
| Return on Capital Employed (ROCE) | 245.90% | -804.60% | -55.10% | -209.40% | -72.60% | -31.80% | |
| Earnings Yield | -3.22% | -47.53% | -12.69% | -45.21% | -18.47% | -7.07% | |
| FCF Yield | -1.95% | -14.23% | -4.09% | -29.48% | -11.83% | -5.82% | |
| Buyback Yield / Dilution | -10.33% | -27.99% | -5.96% | -0.34% | -42.43% | -12.73% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.